FDA Postpones VRBPAC Meeting to Review Pfizer COVID-19 Vaccine EUA Request for Young Children
The U.S. Food and Drug Administration (FDA) announced today it is postponing the Vaccines and Related Biological Products Advisory Committee (VRBPAC) meeting originally scheduled for Monday, February 15 to review the emergency use authorization (EUA) request from Pfizer and BioNTech for the COVID-19 vaccine in children six months through four years of age. The FDA…
Read More »